{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:12:32Z","timestamp":1793592752140,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-024-02426-7","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T03:59:31Z","timestamp":1735185571000},"page":"1081-1095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effectiveness of most common adjuvant wound treatments (skin substitutes, negative pressure wound therapy, hyperbaric oxygen therapy, platelet-rich plasma\/fibrin, and growth factors) for the management of hard-to-heal diabetic foot ulcers: a meta-analysis of randomized controlled trials for the development of the Italian Guidelines for the Treatment of Diabetic Foot Syndrome"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9349-828X","authenticated-orcid":false,"given":"Matteo","family":"Monami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Scatena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Ragghianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Silverii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Uccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Vermigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Panel of the Italian Guidelines for the Treatment of Diabetic Foot Syndrome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bernetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Bordieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cappella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cassai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lorenzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Medea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germano","family":"Scevola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stefanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Tramonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of SID and AMD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"issue":"7","key":"2426_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jcjd.2020.11.011","volume":"45","author":"R Aronson","year":"2021","unstructured":"Aronson R, Chu L, Joseph N, Brown R (2021) Prevalence and risk evaluation of diabetic complications of the foot among adults with type 1 and type 2 diabetes in a large Canadian population (PEDAL Study). Can J Diabetes 45(7):588\u2013593. https:\/\/doi.org\/10.1016\/j.jcjd.2020.11.011","journal-title":"Can J Diabetes"},{"issue":"10","key":"2426_CR2","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2337\/dc12-0200","volume":"35","author":"S Morbach","year":"2012","unstructured":"Morbach S, Furchert H, Gr\u00f6blinghoff U, Hoffmeier H, Kersten K, Klauke GT et al (2012) Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care 35(10):2021\u20132027. https:\/\/doi.org\/10.2337\/dc12-0200","journal-title":"Diabetes Care"},{"issue":"4","key":"2426_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ejvs.2014.06.041","volume":"48","author":"T Elgzyri","year":"2014","unstructured":"Elgzyri T, Larsson J, Nyberg P, Th\u00f6rne J, Eriksson KF, Apelqvist J (2014) Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg 48(4):440\u2013446. https:\/\/doi.org\/10.1016\/j.ejvs.2014.06.041","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"2426_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/clinids\/23.2.286","volume":"23","author":"JS Tan","year":"1996","unstructured":"Tan JS, Friedman NM, Hazelton-Miller C, Flanagan JP, File TM Jr (1996) Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Clin Infect Dis 23(2):286\u2013291. https:\/\/doi.org\/10.1093\/clinids\/23.2.286","journal-title":"Clin Infect Dis"},{"key":"2426_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02246-9","author":"M Meloni","year":"2024","unstructured":"Meloni M, Giurato L, Monge L, Miranda C, Scatena A, Ragghianti B et al (2024) Effect of a multidisciplinary team approach in patients with diabetic foot ulcers on major adverse limb events (MALEs): systematic review and meta-analysis for the development of the Italian guidelines for the treatment of diabetic foot syndrome. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-024-02246-9","journal-title":"Acta Diabetol"},{"key":"2426_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02185-x","author":"A Scatena","year":"2023","unstructured":"Scatena A, Apicella M, Mantuano M, Liistro F, Ventoruzzo G, Petruzzi P et al (2023) Bypass surgery versus endovascular revascularization for occlusive infrainguinal peripheral artery disease: a meta-analysis of randomized controlled trials for the development of the Italian Guidelines for the treatment of diabetic foot syndrome. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-023-02185-x","journal-title":"Acta Diabetol"},{"issue":"Suppl 1","key":"2426_CR7","doi-asserted-by":"publisher","first-page":"e3280","DOI":"10.1002\/dmrr.3280","volume":"36","author":"BA Lipsky","year":"2020","unstructured":"Lipsky BA, Senneville \u00c9, Abbas ZG, Arag\u00f3n-S\u00e1nchez J, Diggle M, Embil JM et al (2020) Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev 36(Suppl 1):e3280. https:\/\/doi.org\/10.1002\/dmrr.3280","journal-title":"Diabetes Metab Res Rev"},{"key":"2426_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02262-9","author":"C Gauna","year":"2024","unstructured":"Gauna C, Romeo F, Scatena A, Miranda C, Uccioli L, Vermigli C et al (2024) Offloading systems for the treatment of neuropathic foot ulcers in patients with diabetes mellitus: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-024-02262-9","journal-title":"Acta Diabetol"},{"key":"2426_CR9","doi-asserted-by":"publisher","first-page":"4915402","DOI":"10.1155\/2022\/4915402","volume":"2022","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chao N, Yin D (2022) A net meta-analysis of the effectiveness of different types of dressings in the treatment of diabetic foot. Comput Math Methods Med 2022:4915402. https:\/\/doi.org\/10.1155\/2022\/4915402","journal-title":"Comput Math Methods Med"},{"issue":"1","key":"2426_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12020-019-02164-9","volume":"68","author":"P Rys","year":"2020","unstructured":"Rys P, Borys S, Hohendorff J, Zapala A, Witek P, Monica M et al (2020) NPWT in diabetic foot wounds-a systematic review and meta-analysis of observational studies. Endocrine 68(1):44\u201355. https:\/\/doi.org\/10.1007\/s12020-019-02164-9","journal-title":"Endocrine"},{"issue":"3","key":"2426_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/1534734620914439","volume":"20","author":"CMD Santos","year":"2021","unstructured":"Santos CMD, Rocha RBD, Hazime FA, Cardoso VS (2021) A systematic review and meta-analysis of the effects of low-level laser therapy in the treatment of diabetic foot ulcers. Int J Low Extrem Wounds 20(3):198\u2013207. https:\/\/doi.org\/10.1177\/1534734620914439","journal-title":"Int J Low Extrem Wounds"},{"issue":"1","key":"2426_CR12","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/s41598-021-81886-1","volume":"11","author":"R Sharma","year":"2021","unstructured":"Sharma R, Sharma SK, Mudgal SK, Jelly P, Thakur K (2021) Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials. Sci Rep 11(1):2189. https:\/\/doi.org\/10.1038\/s41598-021-81886-1","journal-title":"Sci Rep"},{"issue":"2","key":"2426_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/jocd.12853","volume":"18","author":"Z Shen","year":"2019","unstructured":"Shen Z, Zheng S, Chen G, Li D, Jiang Z, Li Y et al (2019) Efficacy and safety of platelet-rich plasma in treating cutaneous ulceration: a meta-analysis of randomized controlled trials. J Cosmet Dermatol 18(2):495\u2013507. https:\/\/doi.org\/10.1111\/jocd.12853","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"2426_CR14","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/iwj.13377","volume":"17","author":"DY Zhao","year":"2020","unstructured":"Zhao DY, Su YN, Li YH, Yu TQ, Li J, Tu CQ (2020) Efficacy and safety of recombinant human epidermal growth factor for diabetic foot ulcers: a systematic review and meta-analysis of randomised controlled trials. Int Wound J 17(4):1062\u20131073. https:\/\/doi.org\/10.1111\/iwj.13377","journal-title":"Int Wound J"},{"issue":"6","key":"2426_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.25270\/wnds\/2022.175177","volume":"34","author":"L Bolton","year":"2022","unstructured":"Bolton L (2022) Diabetic foot ulcer: treatment challenges. Wounds 34(6):175\u2013177. https:\/\/doi.org\/10.25270\/wnds\/2022.175177","journal-title":"Wounds"},{"issue":"1","key":"2426_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00423-024-03230-1","volume":"409","author":"J Gao","year":"2024","unstructured":"Gao J, Ge LX, Gao QY, Zhang AM, Hu LJ (2024) Efficacy of acellular fish skin graft in the management of chronic ulcer: a systematic review and meta-analysis. Langenbecks Arch Surg 409(1):64. https:\/\/doi.org\/10.1007\/s00423-024-03230-1","journal-title":"Langenbecks Arch Surg"},{"key":"2426_CR17","doi-asserted-by":"publisher","DOI":"10.2337\/db2022-02","author":"AJM Boulton","year":"2022","unstructured":"Boulton AJM, Armstrong DG, L\u00f6ndahl M, Frykberg RG, Game FL, Edmonds ME et al (2022) New evidence-based therapies for complex diabetic foot wounds. ADA Clin Compendia. https:\/\/doi.org\/10.2337\/db2022-02","journal-title":"ADA Clin Compendia"},{"issue":"1","key":"2426_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/iwj.13858","volume":"20","author":"F Gong","year":"2023","unstructured":"Gong F, Zhang Y, Gao J, Li X, Zhang H, Ma G et al (2023) Effect of platelet-rich plasma vs standard management for the treatment of diabetic foot ulcer wounds: a meta-analysis. Int Wound J 20(1):155\u2013163. https:\/\/doi.org\/10.1111\/iwj.13858","journal-title":"Int Wound J"},{"issue":"2","key":"2426_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/09546634.2020.1773386","volume":"33","author":"J Chen","year":"2022","unstructured":"Chen J, Wan Y, Lin Y, Jiang H (2022) Platelet-rich fibrin and concentrated growth factors as novel platelet concentrates for chronic hard-to-heal skin ulcers: a systematic review and Meta-analysis of randomized controlled trials. J Dermatolog Treat 33(2):613\u2013621. https:\/\/doi.org\/10.1080\/09546634.2020.1773386","journal-title":"J Dermatolog Treat"},{"key":"2426_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12090881","author":"R Naomi","year":"2020","unstructured":"Naomi R, Fauzi MB (2020) Cellulose\/collagen dressings for diabetic foot ulcer: a review. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics12090881","journal-title":"Pharmaceutics"},{"issue":"8","key":"2426_CR21","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/circresaha.116.309045","volume":"120","author":"M Rigato","year":"2017","unstructured":"Rigato M, Monami M, Fadini GP (2017) Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies. Circ Res 120(8):1326\u20131340. https:\/\/doi.org\/10.1161\/circresaha.116.309045","journal-title":"Circ Res"},{"issue":"4","key":"2426_CR22","doi-asserted-by":"publisher","first-page":"e14886","DOI":"10.1111\/iwj.14886","volume":"21","author":"N Zhang","year":"2024","unstructured":"Zhang N, Liu Y, Yan W, Liu F (2024) The effect of negative pressure wound therapy on the outcome of diabetic foot ulcers: a meta-analysis. Int Wound J 21(4):e14886. https:\/\/doi.org\/10.1111\/iwj.14886","journal-title":"Int Wound J"},{"issue":"4","key":"2426_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/wound.2022.0041","volume":"12","author":"MJ Carter","year":"2023","unstructured":"Carter MJ, Frykberg RG, Oropallo A, Sen CK, Armstrong DG, Nair HKR et al (2023) Efficacy of topical wound oxygen therapy in healing chronic diabetic foot ulcers: systematic review and meta-analysis. Adv Wound Care (New Rochelle) 12(4):177\u2013186. https:\/\/doi.org\/10.1089\/wound.2022.0041","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"1","key":"2426_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.asjsur.2021.07.047","volume":"45","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang W, Xu Y, Liu D (2022) Efficacy of hyperbaric oxygen therapy for diabetic foot ulcers: an updated systematic review and meta-analysis. Asian J Surg 45(1):68\u201378. https:\/\/doi.org\/10.1016\/j.asjsur.2021.07.047","journal-title":"Asian J Surg"},{"key":"2426_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02150-8","author":"M Monami","year":"2023","unstructured":"Monami M, Scatena A, Miranda C, Monge L, De Cassai A, Volpe A et al (2023) Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-023-02150-8","journal-title":"Acta Diabetol"},{"issue":"2","key":"2426_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","volume":"66","author":"GH Guyatt","year":"2013","unstructured":"Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R et al (2013) GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol 66(2):158\u2013172. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.01.012","journal-title":"J Clin Epidemiol"},{"key":"2426_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.12688\/f1000research.121712.2","volume":"11","author":"F Rahim","year":"2022","unstructured":"Rahim F, Yan X, Shah JA, Bibi N, Khan ZU, Nawaz S et al (2022) Epidermal growth factor outperforms placebo in the treatment of diabetic foot ulcer: a meta-analysis. F1000Res 11:773. https:\/\/doi.org\/10.12688\/f1000research.121712.2","journal-title":"F1000Res"},{"issue":"10","key":"2426_CR28","doi-asserted-by":"publisher","first-page":"10830","DOI":"10.21037\/apm-21-2476","volume":"10","author":"L Chen","year":"2021","unstructured":"Chen L, Zhang S, Da J, Wu W, Ma F, Tang C et al (2021) A systematic review and meta-analysis of efficacy and safety of negative pressure wound therapy in the treatment of diabetic foot ulcer. Ann Palliat Med 10(10):10830\u201310839. https:\/\/doi.org\/10.21037\/apm-21-2476","journal-title":"Ann Palliat Med"},{"issue":"1","key":"2426_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12902-024-01550-3","volume":"24","author":"L Sui","year":"2024","unstructured":"Sui L, Xie Q, Jiang HT, Li XD (2024) Effectiveness and safety of dermal matrix used for diabetic foot ulcer: a systematic review and meta-analysis of randomized controlled trials. BMC Endocr Disord 24(1):23. https:\/\/doi.org\/10.1186\/s12902-024-01550-3","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"2426_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/wound.2023.0024","volume":"13","author":"AC Chen","year":"2024","unstructured":"Chen AC, Lu Y, Hsieh CY, Chen YS, Chang KC, Chang DH (2024) Advanced biomaterials and topical medications for treating diabetic foot ulcers: a systematic review and network meta-analysis. Adv Wound Care (New Rochelle) 13(2):97\u2013113. https:\/\/doi.org\/10.1089\/wound.2023.0024","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"4","key":"2426_CR31","first-page":"264","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J (2009) Altman DGJAoim. Prefer Rep Items Syst Rev Meta-anal PRISMA Statement 151(4):264\u2013269","journal-title":"Prefer Rep Items Syst Rev Meta-anal PRISMA Statement"},{"key":"2426_CR32","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"issue":"6","key":"2426_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/ejvs.2002.1911","volume":"25","author":"A Abidia","year":"2003","unstructured":"Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM et al (2003) The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg 25(6):513\u2013518. https:\/\/doi.org\/10.1053\/ejvs.2002.1911","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"2426_CR34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/iwj.13759","volume":"19","author":"DG Armstrong","year":"2022","unstructured":"Armstrong DG, Galiano RD, Orgill DP, Glat PM, Carter MJ, Di Domenico LA et al (2022) Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers. Int Wound J 19(4):932\u2013944. https:\/\/doi.org\/10.1111\/iwj.13759","journal-title":"Int Wound J"},{"issue":"9498","key":"2426_CR35","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/s0140-6736(05)67695-7","volume":"366","author":"DG Armstrong","year":"2005","unstructured":"Armstrong DG, Lavery LA (2005) Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 366(9498):1704\u20131710. https:\/\/doi.org\/10.1016\/s0140-6736(05)67695-7","journal-title":"Lancet"},{"issue":"1","key":"2426_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/iwj.13598","volume":"19","author":"DG Armstrong","year":"2022","unstructured":"Armstrong DG, Orgill DP, Galiano R, Glat PM, Didomenico L, Reyzelman A et al (2022) A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis. Int Wound J 19(1):64\u201375. https:\/\/doi.org\/10.1111\/iwj.13598","journal-title":"Int Wound J"},{"issue":"5","key":"2426_CR37","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/iwj.13715","volume":"19","author":"DG Armstrong","year":"2022","unstructured":"Armstrong DG, Orgill DP, Galiano RD, Glat PM, Kaufman JP, Carter MJ et al (2022) Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial. Int Wound J 19(5):1197\u20131209. https:\/\/doi.org\/10.1111\/iwj.13715","journal-title":"Int Wound J"},{"issue":"4","key":"2426_CR38","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2337\/dc07-2196","volume":"31","author":"PA Blume","year":"2008","unstructured":"Blume PA, Walters J, Payne W, Ayala J, Lantis J (2008) Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 31(4):631\u2013636. https:\/\/doi.org\/10.2337\/dc07-2196","journal-title":"Diabetes Care"},{"issue":"3","key":"2426_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1742-481X.2006.00209.x","volume":"3","author":"SA Brigido","year":"2006","unstructured":"Brigido SA (2006) The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J 3(3):181\u2013187. https:\/\/doi.org\/10.1111\/j.1742-481X.2006.00209.x","journal-title":"Int Wound J"},{"issue":"10","key":"2426_CR40","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.2337\/diacare.26.10.2853","volume":"26","author":"C Caravaggi","year":"2003","unstructured":"Caravaggi C, De Giglio R, Pritelli C, Sommaria M, Dalla Noce S, Faglia E et al (2003) HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 26(10):2853\u20132859. https:\/\/doi.org\/10.2337\/diacare.26.10.2853","journal-title":"Diabetes Care"},{"issue":"3","key":"2426_CR41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/wrr.12551","volume":"25","author":"S Cazzell","year":"2017","unstructured":"Cazzell S, Vayser D, Pham H, Walters J, Reyzelman A, Samsell B et al (2017) A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Wound Repair Regen 25(3):483\u2013497. https:\/\/doi.org\/10.1111\/wrr.12551","journal-title":"Wound Repair Regen"},{"issue":"3","key":"2426_CR42","first-page":"112","volume":"38","author":"N Doctor","year":"1992","unstructured":"Doctor N, Pandya S, Supe A (1992) Hyperbaric oxygen therapy in diabetic foot. J Postgrad Med 38(3):112\u2013114","journal-title":"J Postgrad Med"},{"issue":"6","key":"2426_CR43","first-page":"68","volume":"52","author":"VR Driver","year":"2006","unstructured":"Driver VR, Hanft J, Fylling CP, Beriou JM (2006) A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 52(6):68\u201370","journal-title":"Ostomy Wound Manage"},{"issue":"6","key":"2426_CR44","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/wrr.12357","volume":"23","author":"VR Driver","year":"2015","unstructured":"Driver VR, Lavery LA, Reyzelman AM, Dutra TG, Dove CR, Kotsis SV et al (2015) A clinical trial of integra template for diabetic foot ulcer treatment. Wound Repair Regen 23(6):891\u2013900. https:\/\/doi.org\/10.1111\/wrr.12357","journal-title":"Wound Repair Regen"},{"issue":"6","key":"2426_CR45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1053\/j.jfas.2008.08.002","volume":"47","author":"AP Duzgun","year":"2008","unstructured":"Duzgun AP, Satir HZ, Ozozan O, Saylam B, Kulah B, Coskun F (2008) Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. J Foot Ankle Surg 47(6):515\u2013519. https:\/\/doi.org\/10.1053\/j.jfas.2008.08.002","journal-title":"J Foot Ankle Surg"},{"issue":"1","key":"2426_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1534734609331597","volume":"8","author":"M Edmonds","year":"2009","unstructured":"Edmonds M (2009) Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds 8(1):11\u201318. https:\/\/doi.org\/10.1177\/1534734609331597","journal-title":"Int J Low Extrem Wounds"},{"issue":"4","key":"2426_CR47","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00268-019-05316-0","volume":"44","author":"A Elsaid","year":"2020","unstructured":"Elsaid A, El-Said M, Emile S, Youssef M, Khafagy W, Elshobaky A (2020) Randomized controlled trial on autologous platelet-rich plasma versus saline dressing in treatment of non-healing diabetic foot ulcers. World J Surg 44(4):1294\u20131301. https:\/\/doi.org\/10.1007\/s00268-019-05316-0","journal-title":"World J Surg"},{"issue":"12","key":"2426_CR48","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2337\/diacare.19.12.1338","volume":"19","author":"E Faglia","year":"1996","unstructured":"Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Oriani G et al (1996) Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 19(12):1338\u20131343. https:\/\/doi.org\/10.2337\/diacare.19.12.1338","journal-title":"Diabetes Care"},{"issue":"3","key":"2426_CR49","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2337\/dc15-2001","volume":"39","author":"L Fedorko","year":"2016","unstructured":"Fedorko L, Bowen JM, Jones W, Oreopoulos G, Goeree R, Hopkins RB et al (2016) Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: a prospective, double-blind. Randomized controlled clinical trial. Diabetes Care 39(3):392\u2013399. https:\/\/doi.org\/10.2337\/dc15-2001","journal-title":"Diabetes Care"},{"issue":"4","key":"2426_CR50","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/iwj.13679","volume":"19","author":"LJ Gould","year":"2022","unstructured":"Gould LJ, Orgill DP, Armstrong DG, Galiano RD, Glat PM, Zelen CM et al (2022) Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi-centre clinical trial with a microvascular tissue allograft. Int Wound J 19(4):811\u2013825. https:\/\/doi.org\/10.1111\/iwj.13679","journal-title":"Int Wound J"},{"issue":"9","key":"2426_CR51","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/01.ASW.0000577140.19174.9e","volume":"32","author":"W Gude","year":"2019","unstructured":"Gude W, Hagan D, Abood F, Clausen P (2019) Aurix gel is an effective intervention for chronic diabetic foot ulcers: a pragmatic randomized controlled trial. Adv Skin Wound Care 32(9):416\u2013426. https:\/\/doi.org\/10.1097\/01.ASW.0000577140.19174.9e","journal-title":"Adv Skin Wound Care"},{"issue":"5","key":"2426_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.ASW.0000741512.57300.6d","volume":"34","author":"HM Hahn","year":"2021","unstructured":"Hahn HM, Lee DH, Lee IJ (2021) Ready-to-use micronized human acellular dermal matrix to accelerate wound healing in diabetic foot ulcers: a prospective randomized pilot study. Adv Skin Wound Care 34(5):1\u20136. https:\/\/doi.org\/10.1097\/01.ASW.0000741512.57300.6d","journal-title":"Adv Skin Wound Care"},{"key":"2426_CR53","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.avsg.2021.10.061","volume":"82","author":"EM Hossam","year":"2022","unstructured":"Hossam EM, Alserr AHK, Antonopoulos CN, Zaki A, Eldaly W (2022) Autologous platelet rich plasma promotes the healing of non-ischemic diabetic foot ulcers. A randomized controlled trial. Ann Vasc Surg 82:165\u2013171. https:\/\/doi.org\/10.1016\/j.avsg.2021.10.061","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"2426_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/joacp.JOACP_94_19","volume":"36","author":"A Kumar","year":"2020","unstructured":"Kumar A, Shukla U, Prabhakar T, Srivastava D (2020) Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers. J Anaesthesiol Clin Pharmacol 36(2):213\u2013218. https:\/\/doi.org\/10.4103\/joacp.JOACP_94_19","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"Sub7","key":"2426_CR55","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.12968\/jowc.2021.30.Sup7.S18","volume":"30","author":"JC Lantis","year":"2021","unstructured":"Lantis JC, Snyder R, Reyzelman AM, Van Gils CC, Sigal F, Vayser D et al (2021) Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial. J Wound Care 30(Sub7):S18\u2013S27. https:\/\/doi.org\/10.12968\/jowc.2021.30.Sup7.S18","journal-title":"J Wound Care"},{"issue":"5","key":"2426_CR56","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/iwj.12329","volume":"11","author":"LA Lavery","year":"2014","unstructured":"Lavery LA, Fulmer J, Shebetka KA, Regulski M, Vayser D, Fried D et al (2014) The efficacy and safety of Grafix(\u00ae) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J 11(5):554\u2013560. https:\/\/doi.org\/10.1111\/iwj.12329","journal-title":"Int Wound J"},{"issue":"5","key":"2426_CR57","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2337\/dc09-1754","volume":"33","author":"M L\u00f6ndahl","year":"2010","unstructured":"L\u00f6ndahl M, Katzman P, Nilsson A, Hammarlund C (2010) Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 33(5):998\u20131003. https:\/\/doi.org\/10.2337\/dc09-1754","journal-title":"Diabetes Care"},{"issue":"7","key":"2426_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.25270\/wnds\/2021.169177","volume":"33","author":"EJ Lullove","year":"2021","unstructured":"Lullove EJ, Liden B, Winters C, McEneaney P, Raphael A, Lantis Ii JC (2021) A multicenter, blinded, randomized controlled clinical trial evaluating the effect of omega-3-rich fish skin in the treatment of chronic. Nonresponsive diabetic foot ulcers. Wounds 33(7):169\u2013177. https:\/\/doi.org\/10.25270\/wnds\/2021.169177","journal-title":"Wounds"},{"issue":"4","key":"2426_CR59","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s13410-021-00941-9","volume":"41","author":"N Malekpour Alamdari","year":"2021","unstructured":"Malekpour Alamdari N, Mehraneroodi B, Gholizadeh B, Zeinalpour A, Safe P, Besharat S (2021) The efficacy of negative pressure wound therapy compared with conventional dressing in treating infected diabetic foot ulcers: a randomized controlled trial. Int J Diabet Develop Ctries 41(4):664\u2013668. https:\/\/doi.org\/10.1007\/s13410-021-00941-9","journal-title":"Int J Diabet Develop Ctries"},{"issue":"2","key":"2426_CR60","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.dsx.2021.03.005","volume":"15","author":"N Malekpour Alamdari","year":"2021","unstructured":"Malekpour Alamdari N, Shafiee A, Mirmohseni A, Besharat S (2021) Evaluation of the efficacy of platelet-rich plasma on healing of clean diabetic foot ulcers: a randomized clinical trial in Tehran, Iran. Diabetes Metab Syndr 15(2):621\u2013626. https:\/\/doi.org\/10.1016\/j.dsx.2021.03.005","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"2426_CR61","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/iwj.13646","volume":"19","author":"L Manning","year":"2022","unstructured":"Manning L, Ferreira IB, Gittings P, Hiew J, Ryan E, Baba M et al (2022) Wound healing with \u201cspray-on\u201d autologous skin grafting (ReCell) compared with standard care in patients with large diabetes-related foot wounds: an open-label randomised controlled trial. Int Wound J 19(3):470\u2013481. https:\/\/doi.org\/10.1111\/iwj.13646","journal-title":"Int Wound J"},{"issue":"1","key":"2426_CR62","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.dsx.2021.01.014","volume":"15","author":"H Maranna","year":"2021","unstructured":"Maranna H, Lal P, Mishra A, Bains L, Sawant G, Bhatia R et al (2021) Negative pressure wound therapy in grade 1 and 2 diabetic foot ulcers: a randomized controlled study. Diabetes Metab Syndr 15(1):365\u2013371. https:\/\/doi.org\/10.1016\/j.dsx.2021.01.014","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"2426_CR63","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2337\/diacare.26.6.1701","volume":"26","author":"WA Marston","year":"2003","unstructured":"Marston WA, Hanft J, Norwood P, Pollak R (2003) The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26(6):1701\u20131705. https:\/\/doi.org\/10.2337\/diacare.26.6.1701","journal-title":"Diabetes Care"},{"issue":"Pt B","key":"2426_CR64","doi-asserted-by":"publisher","first-page":"108282","DOI":"10.1016\/j.intimp.2021.108282","volume":"101","author":"R Meamar","year":"2021","unstructured":"Meamar R, Ghasemi-Mobarakeh L, Norouzi MR, Siavash M, Hamblin MR, Fesharaki M (2021) Improved wound healing of diabetic foot ulcers using human placenta-derived mesenchymal stem cells in gelatin electrospun nanofibrous scaffolds plus a platelet-rich plasma gel: a randomized clinical trial. Int Immunopharmacol 101(Pt B):108282. https:\/\/doi.org\/10.1016\/j.intimp.2021.108282","journal-title":"Int Immunopharmacol"},{"key":"2426_CR65","doi-asserted-by":"publisher","first-page":"109775","DOI":"10.1016\/j.diabres.2022.109775","volume":"185","author":"A Mohammadi Tofigh","year":"2022","unstructured":"Mohammadi Tofigh A, Tajik M (2022) Comparing the standard surgical dressing with dehydrated amnion and platelet-derived growth factor dressings in the healing rate of diabetic foot ulcer: a randomized clinical trial. Diabet Res Clin Pract 185:109775. https:\/\/doi.org\/10.1016\/j.diabres.2022.109775","journal-title":"Diabet Res Clin Pract"},{"issue":"5 Pt 1","key":"2426_CR66","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00129334-200506000-00012","volume":"18","author":"JA Niezgoda","year":"2005","unstructured":"Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP (2005) Randomized clinical trial comparing OASIS wound matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care 18(5 Pt 1):258\u2013266. https:\/\/doi.org\/10.1097\/00129334-200506000-00012","journal-title":"Adv Skin Wound Care"},{"key":"2426_CR67","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.diabres.2018.06.002","volume":"142","author":"KH Park","year":"2018","unstructured":"Park KH, Han SH, Hong JP, Han SK, Lee DH, Kim BS et al (2018) Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: a phase III multicenter, double-blind, randomized, placebo-controlled trial. Diabet Res Clin Pract 142:335\u2013344. https:\/\/doi.org\/10.1016\/j.diabres.2018.06.002","journal-title":"Diabet Res Clin Pract"},{"issue":"3","key":"2426_CR68","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1742-481X.2009.00585.x","volume":"6","author":"A Reyzelman","year":"2009","unstructured":"Reyzelman A, Crews RT, Moore JC, Moore L, Mukker JS, Offutt S et al (2009) Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J 6(3):196\u2013208. https:\/\/doi.org\/10.1111\/j.1742-481X.2009.00585.x","journal-title":"Int Wound J"},{"issue":"1","key":"2426_CR69","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2337\/dc17-0654","volume":"41","author":"KTB Santema","year":"2018","unstructured":"Santema KTB, Stoekenbroek RM, Koelemay MJW, Reekers JA, van Dortmont LMC, Oomen A et al (2018) Hyperbaric oxygen therapy in the treatment of ischemic lower- extremity ulcers in patients with diabetes: results of the DAMO(2)CLES multicenter randomized clinical trial. Diabetes Care 41(1):112\u2013119. https:\/\/doi.org\/10.2337\/dc17-0654","journal-title":"Diabetes Care"},{"issue":"3","key":"2426_CR70","doi-asserted-by":"publisher","first-page":"e026345","DOI":"10.1136\/bmjopen-2018-026345","volume":"10","author":"D Seidel","year":"2020","unstructured":"Seidel D, Storck M, Lawall H, Wozniak G, Mauckner P, Hochlenert D et al (2020) Negative pressure wound therapy compared with standard moist wound care on diabetic foot ulcers in real-life clinical practice: results of the German DiaFu-RCT. BMJ Open 10(3):e026345. https:\/\/doi.org\/10.1136\/bmjopen-2018-026345","journal-title":"BMJ Open"},{"issue":"1","key":"2426_CR71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2217\/cer-2019-0142","volume":"9","author":"TE Serena","year":"2020","unstructured":"Serena TE, Yaakov R, Moore S, Cole W, Coe S, Snyder R et al (2020) A randomized controlled clinical trial of a hypothermically stored amniotic membrane for use in diabetic foot ulcers. J Comp Eff Res 9(1):23\u201334. https:\/\/doi.org\/10.2217\/cer-2019-0142","journal-title":"J Comp Eff Res"},{"issue":"2","key":"2426_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.25270\/wnds\/2022.5767","volume":"33","author":"R Shetty","year":"2022","unstructured":"Shetty R, Giridhar BS, Potphode A (2022) Role of ultrathin skin graft in early healing of diabetic foot ulcers: a randomized controlled trial in comparison with conventional methods. Wounds 33(2):57\u201367. https:\/\/doi.org\/10.25270\/wnds\/2022.5767","journal-title":"Wounds"},{"issue":"11","key":"2426_CR73","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2337\/diacare.15.11.1598","volume":"15","author":"DL Steed","year":"1992","unstructured":"Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW (1992) Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 15(11):1598\u20131604. https:\/\/doi.org\/10.2337\/diacare.15.11.1598","journal-title":"Diabetes Care"},{"issue":"1","key":"2426_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/iwj.12976","volume":"16","author":"W Tettelbach","year":"2019","unstructured":"Tettelbach W, Cazzell S, Reyzelman AM, Sigal F, Caporusso JM, Agnew PS (2019) A confirmatory study on the efficacy of dehydrated human amnion\/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics. Int Wound J 16(1):19\u201329. https:\/\/doi.org\/10.1111\/iwj.12976","journal-title":"Int Wound J"},{"issue":"1","key":"2426_CR75","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/iwj.13001","volume":"16","author":"W Tettelbach","year":"2019","unstructured":"Tettelbach W, Cazzell S, Sigal F, Caporusso JM, Agnew PS, Hanft J et al (2019) A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers. Int Wound J 16(1):122\u2013130. https:\/\/doi.org\/10.1111\/iwj.13001","journal-title":"Int Wound J"},{"issue":"6","key":"2426_CR76","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/01.Asw.0000557831.78645.85","volume":"32","author":"P Thompson","year":"2019","unstructured":"Thompson P, Hanson DS, Langemo D, Anderson J (2019) Comparing human amniotic allograft and standard wound care when using total contact casting in the treatment of patients with diabetic foot ulcers. Adv Skin Wound Care 32(6):272\u2013277. https:\/\/doi.org\/10.1097\/01.Asw.0000557831.78645.85","journal-title":"Adv Skin Wound Care"},{"issue":"6","key":"2426_CR77","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.2337\/diacare.26.6.1856","volume":"26","author":"MW Tsang","year":"2003","unstructured":"Tsang MW, Wong WK, Hung CS, Lai KM, Tang W, Cheung EY et al (2003) Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care 26(6):1856\u20131861. https:\/\/doi.org\/10.2337\/diacare.26.6.1856","journal-title":"Diabetes Care"},{"issue":"2","key":"2426_CR78","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/1534734611409371","volume":"10","author":"L Uccioli","year":"2011","unstructured":"Uccioli L, Giurato L, Ruotolo V, Ciavarella A, Grimaldi MS, Piaggesi A et al (2011) Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up. Int J Low Extrem Wounds 10(2):80\u201385. https:\/\/doi.org\/10.1177\/1534734611409371","journal-title":"Int J Low Extrem Wounds"},{"issue":"2","key":"2426_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2337\/diacare.24.2.290","volume":"24","author":"A Veves","year":"2001","unstructured":"Veves A, Falanga V, Armstrong DG, Sabolinski ML (2001) Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 24(2):290\u2013295. https:\/\/doi.org\/10.2337\/diacare.24.2.290","journal-title":"Diabetes Care"},{"issue":"11","key":"2426_CR80","doi-asserted-by":"publisher","first-page":"521","DOI":"10.12968\/jowc.2014.23.11.521","volume":"23","author":"HJ You","year":"2014","unstructured":"You HJ, Han SK, Rhie JW (2014) Randomised controlled clinical trial for autologous fibroblast-hyaluronic acid complex in treating diabetic foot ulcers. J Wound Care 23(11):521\u2013522. https:\/\/doi.org\/10.12968\/jowc.2014.23.11.521","journal-title":"J Wound Care"},{"issue":"5","key":"2426_CR81","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/iwj.12920","volume":"15","author":"CM Zelen","year":"2018","unstructured":"Zelen CM, Orgill DP, Serena TE, Galiano RE, Carter MJ, DiDomenico LA et al (2018) An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial. Int Wound J 15(5):731\u2013739. https:\/\/doi.org\/10.1111\/iwj.12920","journal-title":"Int Wound J"},{"issue":"2","key":"2426_CR82","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/iwj.12566","volume":"13","author":"CM Zelen","year":"2016","unstructured":"Zelen CM, Serena TE, Gould L, Le L, Carter MJ, Keller J et al (2016) Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost. Int Wound J 13(2):272\u2013282. https:\/\/doi.org\/10.1111\/iwj.12566","journal-title":"Int Wound J"},{"issue":"11","key":"2426_CR83","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/s2213-8587(18)30240-7","volume":"6","author":"F Game","year":"2018","unstructured":"Game F, Jeffcoate W, Tarnow L, Jacobsen JL, Whitham DJ, Harrison EF et al (2018) LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial. Lancet Diabetes Endocrinol 6(11):870\u2013878. https:\/\/doi.org\/10.1016\/s2213-8587(18)30240-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2426_CR84","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00125-010-1946-y","volume":"54","author":"M L\u00f6ndahl","year":"2011","unstructured":"L\u00f6ndahl M, Katzman P, Hammarlund C, Nilsson A, Landin-Olsson M (2011) Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers. Diabetologia 54(1):65\u201368. https:\/\/doi.org\/10.1007\/s00125-010-1946-y","journal-title":"Diabetologia"},{"issue":"11","key":"2426_CR85","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00592-023-02150-8","volume":"60","author":"M Monami","year":"2023","unstructured":"Monami M, Scatena A, Miranda C, Monge L, De Cassai A, Volpe A et al (2023) Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects. Acta Diabetol 60(11):1449\u20131469. https:\/\/doi.org\/10.1007\/s00592-023-02150-8","journal-title":"Acta Diabetol"},{"issue":"2","key":"2426_CR86","doi-asserted-by":"publisher","first-page":"108690","DOI":"10.1016\/j.jdiacomp.2024.108690","volume":"38","author":"M Ruiz-Mu\u00f1oz","year":"2024","unstructured":"Ruiz-Mu\u00f1oz M, Martinez-Barrios FJ, Fernandez-Torres R, Lopezosa-Reca E, Marchena-Rodriguez A (2024) Autologous platelet-rich plasma (APRP) in diabetes foot disease: a meta-analysis. J Diabetes Complications 38(2):108690. https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108690","journal-title":"J Diabetes Complications"},{"issue":"4S Suppl 1","key":"2426_CR87","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1097\/sap.0000000000002096","volume":"83","author":"AJ Gordon","year":"2019","unstructured":"Gordon AJ, Alfonso AR, Nicholson J, Chiu ES (2019) Evidence for healing diabetic foot ulcers with biologic skin substitutes: a systematic review and meta-analysis. Ann Plast Surg 83(4S Suppl 1):S31-s44. https:\/\/doi.org\/10.1097\/sap.0000000000002096","journal-title":"Ann Plast Surg"},{"issue":"4","key":"2426_CR88","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/wrr.12187","volume":"22","author":"R Gomez-Villa","year":"2014","unstructured":"Gomez-Villa R, Aguilar-Rebolledo F, Lozano-Platonoff A, Teran-Soto JM, Fabian-Victoriano MR, Kresch-Tronik NS et al (2014) Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial. Wound Repair Regen 22(4):497\u2013503. https:\/\/doi.org\/10.1111\/wrr.12187","journal-title":"Wound Repair Regen"},{"issue":"5","key":"2426_CR89","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1684\/ejd.2009.0750","volume":"19","author":"H Uchi","year":"2009","unstructured":"Uchi H, Igarashi A, Urabe K, Koga T, Nakayama J, Kawamori R et al (2009) Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 19(5):461\u2013468. https:\/\/doi.org\/10.1684\/ejd.2009.0750","journal-title":"Eur J Dermatol"},{"issue":"2","key":"2426_CR90","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1534734619892791","volume":"19","author":"V Viswanathan","year":"2020","unstructured":"Viswanathan V, Juttada U, Babu M (2020) Efficacy of recombinant human epidermal growth factor (Regen-D 150) in healing diabetic foot ulcers: a hospital-based randomized controlled trial. Int J Low Extrem Wounds 19(2):158\u2013164. https:\/\/doi.org\/10.1177\/1534734619892791","journal-title":"Int J Low Extrem Wounds"},{"issue":"10","key":"2426_CR91","doi-asserted-by":"publisher","first-page":"Cd008548","DOI":"10.1002\/14651858.CD008548.pub2","volume":"2015","author":"AJ Mart\u00ed-Carvajal","year":"2015","unstructured":"Mart\u00ed-Carvajal AJ, Gluud C, Nicola S, Simancas-Racines D, Reveiz L, Oliva P et al (2015) Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev 2015(10):Cd008548. https:\/\/doi.org\/10.1002\/14651858.CD008548.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2426_CR92","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00266-015-0504-x","volume":"39","author":"AP Sclafani","year":"2015","unstructured":"Sclafani AP, Azzi J (2015) Platelet preparations for use in facial rejuvenation and wound healing: a critical review of current literature. Aesthetic Plast Surg 39(4):495\u2013505. https:\/\/doi.org\/10.1007\/s00266-015-0504-x","journal-title":"Aesthetic Plast Surg"},{"issue":"Sup3","key":"2426_CR93","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.12968\/jowc.2017.26.Sup3.S1","volume":"26","author":"J Apelqvist","year":"2017","unstructured":"Apelqvist J, Willy C, Fagerdahl AM, Fraccalvieri M, Malmsj\u00f6 M, Piaggesi A et al (2017) EWMA document: negative pressure wound therapy. J Wound Care 26(Sup3):S1\u2013S154. https:\/\/doi.org\/10.12968\/jowc.2017.26.Sup3.S1","journal-title":"J Wound Care"},{"issue":"6","key":"2426_CR94","doi-asserted-by":"publisher","first-page":"Cd004123","DOI":"10.1002\/14651858.CD004123.pub4","volume":"2015","author":"P Kranke","year":"2015","unstructured":"Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S (2015) Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2015(6):Cd004123. https:\/\/doi.org\/10.1002\/14651858.CD004123.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"2426_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02320-2","author":"M Monami","year":"2024","unstructured":"Monami M, Ragghianti B, Scatena A, Miranda C, Monge L, Uccioli L et al (2024) Effectiveness of different advanced wound dressings versus standard of care for the management of diabetic foot ulcers: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-024-02320-2","journal-title":"Acta Diabetol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02426-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-024-02426-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02426-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T12:18:36Z","timestamp":1753186716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-024-02426-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":95,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2426"],"URL":"https:\/\/doi.org\/10.1007\/s00592-024-02426-7","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The other authors do not have any direct relevant conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}